The Prof G Pod with Scott Galloway

Podbit · The Prof G Pod with Scott Galloway

Prof G Markets: Google’s Quantum Breakthrough & The World Cup Goes to Saudi Arabia

Explore episode Dec 16, 2024

Where this was said

GLP-1 Drugs vs. the Alcohol Industry

At 18:46 · chapter starts 16:36

The GLP-1 segment is where the episode finds its sharpest edge. Ed introduces the Eli Lilly news with a new vocabulary term from the CEO: 'anti-hedonics' — drugs that reduce the brain's desire cycle. Scott's framing is more visceral: these drugs are 'scaffolding on our instincts,' updating human biology for a world of industrial-scale food and alcohol production. The numbers are alarming for the drinks sector: Loyola University peer-reviewed research shows a 40% lower opioid overdose rate and 50% lower alcohol intoxication rate for GLP-1 users. Ed catalogs the carnage already underway — Boston Beer down 9%, AB InBev down 15%, Brown-Forman down 20% in a year. Scott delivers the most important insight: the alcohol industry is not built on social drinkers — it's built on the 1% of people who drink 27 beers a day. Those are exactly the people who will get GLP-1 prescriptions first, from doctors telling them they'll die if they keep drinking. When you remove those alcoholic customers, the industry's revenue drops 20-30%, which 'spells restructuring, massive layoffs, a meltdown.' Ed adds the J.M. Smucker CEO's tone-deaf earnings call response — 'snacking continues' — as darkly comic proof of how deep the denial runs. Scott closes the loop: young people have already abandoned alcohol in favor of edibles and other substances, making the drinks industry a slow-motion version of the cable TV collapse.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.